Hyperglycemia in Neurosurgery

Completed

Conditions studied: Hyperglycemia, Postoperative Infection

In brief

Poor glycemic control is recognized as a risk factor for postoperative infection. For the neurosurgical patient, postoperative infection can lead to devastating complications such as meningitis, encephalitis and death. Neurosurgical patients often receive high doses of medications that increase blood glucose levels such as steroids, placing them at a potentially higher risk for postoperative infection. The purpose of this multisite observational study is to assess the impact of severe intraoperative hyperglycemia as a risk factor for postoperative infection in the neurosurgical patient.

Key facts

Study ID

NCT05236751

Run by

Boston Medical Center

People needed

52

Starts

2021-05-24

Expected to finish

2023-05-13

Last updated by the study team

2023-09-28

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult patients scheduled for elective intracranial (open surgical or endoscopic) intervention
• General anesthesia
• Hospital stay of at least 1 day post-procedure

You may not qualify if…

• Diagnosis of infection (local or systemic) in preoperative period
• Emergency procedures

Where it is running

• Boston Medical Center — Boston, Massachusetts, United States
• Sapienza University — Rome, Italy
• Burdenko Neurosurgery Institute — Moscow, Russia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.